Lumexa Imaging (NASDAQ:LMRI) Trading 10% Higher – Time to Buy?

Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI)’s stock price traded up 10% during mid-day trading on Thursday . The company traded as high as $8.11 and last traded at $8.2610. 18,410 shares were traded during mid-day trading, a decline of 98% from the average session volume of 873,506 shares. The stock had previously closed at $7.51.

Analyst Ratings Changes

A number of research analysts have issued reports on the company. Raymond James Financial raised Lumexa Imaging from an “outperform” rating to a “strong-buy” rating and set a $23.00 price target for the company in a report on Monday, February 9th. Weiss Ratings raised Lumexa Imaging from a “sell (e-)” rating to a “sell (e)” rating in a report on Monday. Finally, Barclays decreased their price target on Lumexa Imaging from $15.00 to $9.00 and set an “overweight” rating for the company in a report on Wednesday, May 20th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $16.00.

Lumexa Imaging Stock Up 6.2%

The stock’s fifty day moving average is $8.89.

Insider Buying and Selling

In other Lumexa Imaging news, Director Brett Brodnax acquired 35,000 shares of the company’s stock in a transaction on Tuesday, May 19th. The shares were bought at an average cost of $7.25 per share, with a total value of $253,750.00. Following the completion of the acquisition, the director owned 62,027 shares in the company, valued at approximately $449,695.75. This trade represents a 129.50% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 0.70% of the company’s stock.

Institutional Trading of Lumexa Imaging

Several institutional investors have recently bought and sold shares of LMRI. Bank of America Corp DE lifted its position in shares of Lumexa Imaging by 1,855,116.7% in the first quarter. Bank of America Corp DE now owns 111,313 shares of the company’s stock valued at $957,000 after acquiring an additional 111,307 shares in the last quarter. Janus Henderson Group PLC increased its position in shares of Lumexa Imaging by 5.4% during the first quarter. Janus Henderson Group PLC now owns 2,100,356 shares of the company’s stock worth $18,063,000 after purchasing an additional 107,903 shares in the last quarter. Readystate Asset Management LP increased its position in shares of Lumexa Imaging by 60.5% during the first quarter. Readystate Asset Management LP now owns 224,755 shares of the company’s stock worth $1,933,000 after purchasing an additional 84,755 shares in the last quarter. Renaissance Technologies LLC purchased a new stake in shares of Lumexa Imaging during the first quarter worth approximately $778,000. Finally, Sei Investments Co. increased its position in shares of Lumexa Imaging by 339.6% during the first quarter. Sei Investments Co. now owns 88,190 shares of the company’s stock worth $758,000 after purchasing an additional 68,127 shares in the last quarter.

Lumexa Imaging Company Profile

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).